Swiss clinical tech firm Vtuls is offering its remote healthcare monitoring technology to UK care homes for no charge.

The system monitors patients’ vital signs using artificial intelligence (AI) and machine learning to alert clinicians when conditions deteriorate.

The technology is CE marked and US Food and Drug Administration (FDA) approved, and has been deployed in seven countries. It can track over 40 vital signs including temperature, blood oxygen, blood pressure and pain.

Data from the UK Office of National Statistics (ONS) shows that Covid-19 has been responsible for more than one in four care home deaths in the country over the last two months.

Vtuls founder and CEO Jas Saini said: “Earlier detection of Covid-19 cases in care homes would enable faster treatment of infected residents and reduce cluster outbreaks that occur when residents are isolated too slowly.

“Daily remote health monitoring of vital signs could play an important part in this. Not only would it uncover suspected cases earlier, therefore enabling better targeting of testing resources, it would also catch cases that occur after a resident has been given the all-clear from a previous test, that would otherwise not be picked up until much later.”